SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-009481
Filing Date
2024-03-06
Accepted
2024-03-06 17:40:08
Documents
3
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1709764798.html 4  
1 FORM 4 wk-form4_1709764798.xml 4 6977
2 EX-24 poa_chintu.htm EX-24 2314
3 GRAPHIC poa_chintu001.jpg GRAPHIC 154166
  Complete submission text file 0001628280-24-009481.txt   223184
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER CA 08807
Business Address
Patel Chintu (Reporting) CIK: 0001737428 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 24727285